IL13RA1 and renal cell carcinoma: These results suggest that IL4Rα and IL13Rα1 might be involved in the progression of RCC through JAK2/FOXO3 pathway, and their expression might be used as the novel prognostic factor and promising therapeutic target for RCC patients.